Artiva Biotherapeutics: chief medical officer Banerjee Subhashis sold 1,099 shares

What happened Banerjee Subhashis, chief medical officer, sold 1,099 shares at $6.84 per share on Oct 5, 2026, for $7,514. The filing notes the sale was to satisfy tax withholding obligations in connection with the vesting and release of restricted stock units; the sales were automatic and not at the discretion of the reporting person.

Key details

• Transaction date and price: Oct 5, 2026 — 1,099 shares sold at $6.84 (transaction code S).
• Ownership after the transaction: not reported in the filing.
• Footnote: F1 — issuer adopted a sell-to-cover policy; shares sold represent those required to cover tax withholding for vested RSUs and were automatic.
• Filing date and timeliness: filed Oct 6, 2026; the filing does not indicate it was late.

Why it may matter The filing shows a sell-to-cover tax withholding in connection with RSU vesting; the sale was automatic and not a discretionary open-market decision by the reporting person. A filing does not show why the insider traded or why the company acted.